Single-cell transcriptional profiling reveals cellular and molecular divergence in human maternal–fetal interface

被引:0
作者
Quanlei Wang
Jinlu Li
Shengpeng Wang
Qiuting Deng
Yanru An
Yanan Xing
Xi Dai
Zelong Li
Qiwang Ma
Kuixing Wang
Chuanyu Liu
Yue Yuan
Guoyi Dong
Tao Zhang
Huanming Yang
Yutao Du
Yong Hou
Weilin Ke
Zhouchun Shang
机构
[1] BGI-Shenzhen,College of Life Sciences
[2] University of Chinese Academy of Sciences,Department of Obstetrics, Shenzhen Second People’s Hospital
[3] Shenzhen University 1st Affiliated Hospital,BGI College
[4] James D. Watson Institute of Genome Sciences,undefined
[5] Shenzhen BGI Cell Technology Co.,undefined
[6] Ltd,undefined
[7] Northwest University,undefined
来源
Scientific Reports | / 12卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Placenta plays essential role in successful pregnancy, as the most important organ connecting and interplaying between mother and fetus. However, the cellular characteristics and molecular interaction of cell populations within the fetomaternal interface is still poorly understood. Here, we surveyed the single-cell transcriptomic landscape of human full-term placenta and revealed the heterogeneity of cytotrophoblast cell (CTB) and stromal cell (STR) with the fetal/maternal origin consecutively localized from fetal section (FS), middle section (Mid_S) to maternal section (Mat_S) of maternal–fetal interface. Then, we highlighted a subpopulation of CTB, named trophoblast progenitor-like cells (TPLCs) existed in the full-term placenta and mainly distributed in Mid_S, with high expression of a pool of putative cell surface markers. Further, we revealed the putative key transcription factor PRDM6 that might promote the differentiation of endovascular extravillous trophoblast cells (enEVT) by inhibiting cell proliferation, and down-regulation of PRDM6 might lead to an abnormal enEVT differentiation process in PE. Together, our study offers important resources for better understanding of human placenta and stem cell-based therapy, and provides new insights on the study of tissue heterogeneity, the clinical prevention and control of PE as well as the maternal–fetal interface.
引用
收藏
相关论文
共 115 条
[1]  
Sood R(2006)Gene expression patterns in human placenta Proc. Natl. Acad. Sci. USA 103 5478-5483
[2]  
Zehnder JL(2015)Viewpoint What is the placenta Am. J. Obstet. Gynecol. 213 S6.e1-S6.e4
[3]  
Druzin ML(2013)Placental trophoblast cell differentiation: Physiological regulation and pathological relevance to preeclampsia Mol. Aspects Med. 34 981-1023
[4]  
Brown PO(2017)Preeclampsia: novel insights from global RNA profiling of trophoblast subpopulations Am. J. Obstet. Gynecol. 217 e1-200.e17
[5]  
Burton GJ(2019)Pre-eclampsia: Pathogenesis, novel diagnostics and therapies Nat. Rev. Nephrol. 15 275-289
[6]  
Jauniaux E(2019)Single cell transcriptional signatures of the human placenta in term and preterm parturition Elife 8 969-971
[7]  
Ji L(2014)Novel isolation strategy to deliver pure fetal-origin and maternal-origin mesenchymal stem cell (MSC) populations from human term placenta Placenta 35 1-17
[8]  
Bs MG(2018)Comprehensive characterization of chorionic villi-derived mesenchymal stromal cells from human placenta Stem Cell Res. Ther. 9 S57-S60
[9]  
Phipps EA(2017)Human trophoblast stem cells: Real or not real Placenta 60 2456-2467
[10]  
Thadhani R(2010)ELF5-enforced transcriptional networks define an epigenetically regulated trophoblast stem cell compartment in the human placenta Hum. Mol. Genet. 19 56-61